Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U2 small nuclear 14, pseudogene (RNU2-14P) is classified as a pseudogene of the U2 small nuclear RNA family, located on human chromosome 14[1][2][6]. As a pseudogene, it is thought to be a non-functional genomic sequence that is similar to functional U2 snRNA genes but does not produce a mature, functional RNA product[2][6]. There are no identified protein products, known biological functions, or established clinical or therapeutic roles for this pseudogene. RNU2-14P is not currently considered a therapeutic target, nor is it associated with any drugs, biomarkers, or safety concerns[1][2][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U2 small nuclear 14, pseudogene (RNU2-14P).